Search for dissertations about: "Martin Carlsson"
Showing result 11 - 15 of 21 swedish dissertations containing the words Martin Carlsson.
-
11. The role of the board chair : Changing expectations and hybrid organizations
Abstract : The purpose of this dissertation is to enhance our understanding of the changing role of the board chair and what this means for hybrid organizations and their board work. Historically, the role of the boards and their chairs evolved around safeguarding shareholders’ financial interests. READ MORE
-
12. Cost-effectiveness analysis of health technologies when evidence is scarce
Abstract : Given the increasing pressures on health care budgets, economic evaluation is used in many countries to assist decision-making regarding the optimal use of competing health care technologies. Although the standard methods of estimating cost-effectiveness underpinning these decisions have gained widespread acceptance, concerns have been raised that many technologies would not be considered for funding, due to scarcity of evidence. READ MORE
-
13. Life Strategies, Work and Health in People with Usher Syndrome
Abstract : Introduction: People with Usher syndrome (USH) have an inherited disorder causing congenital deafness or hearing loss combined with progressive vision loss and, in some cases, balance problems. Previous research has shown that people with USH have poor physical and psychological health. READ MORE
-
14. How the sensory ecology of the bumblebee affects their functional traits
Abstract : Morphological traits are important for trait-based ecological studies as they allow for the prediction of biodiversity across the biosphere. Currently, the predictive power of trait-based ecology is not often applied to terrestrial arthropods, even though they provide us with important agricultural, ecological, and cultural value. READ MORE
-
15. The value of evaluating and implementing pharmaceuticals
Abstract : Pharmaceuticals are a central part of high-quality health care and a resource for improving population health. However, high prices set by private companies who develop and own the rights to new pharmaceuticals question the value that they contribute to the health care system. READ MORE